Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 15 filers reported holding Novozymes A/S in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $4,572,000 | -17.0% | 104,352 | -24.9% | 0.04% | -22.2% |
Q1 2017 | $5,507,000 | +41.7% | 138,867 | +23.3% | 0.04% | +50.0% |
Q4 2016 | $3,887,000 | -80.3% | 112,635 | -74.7% | 0.03% | -80.0% |
Q3 2016 | $19,733,000 | +343.4% | 444,846 | +377.1% | 0.15% | +341.2% |
Q2 2016 | $4,450,000 | +15.2% | 93,241 | +8.7% | 0.03% | +30.8% |
Q1 2016 | $3,863,000 | +480.9% | 85,789 | +394.1% | 0.03% | +766.7% |
Q3 2013 | $665,000 | +84.2% | 17,362 | +53.9% | 0.00% | +50.0% |
Q2 2013 | $361,000 | – | 11,280 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lenox Wealth Management, Inc. | 70,039 | $3,834,000 | 1.14% |
GARRISON BRADFORD & ASSOCIATES INC | 15,100 | $827,000 | 0.67% |
Moloney Securities Asset Management, LLC | 31,722 | $1,742,000 | 0.60% |
ZEVIN ASSET MANAGEMENT LLC | 34,729 | $1,901,000 | 0.56% |
HIGH POINTE CAPITAL MANAGEMENT LLC | 6,490 | $356,000 | 0.48% |
BOSTON FINANCIAL MANGEMENT LLC | 102,687 | $5,621,000 | 0.33% |
Boston Common Asset Management, LLC | 18,656 | $1,025,000 | 0.13% |
Hemenway Trust Co LLC | 12,000 | $657,000 | 0.11% |
QUADRANT CAPITAL GROUP LLC | 2,011 | $104,000 | 0.03% |
PARAMETRIC PORTFOLIO ASSOCIATES LLC | 261,819 | $14,332,000 | 0.01% |